HEALTH DEVICES RESEARCH INSTITUTE (HDRI) RECEIVES VENTURE FINANCING FROM BURR, EGAN, DELEAGE AND CO.
REDWOOD CITY, Calif., Aug. 23 /PRNewswire/ -- Health Devices Research Institute (HDRI), an international epidemiologic research organization serving the medical device and pharmaceutical industries, announced today that the company has received capital financing to facilitate continuing growth via Burr, Egan, Deleage and Co. of San Francisco. Terms of the deal were not disclosed. Founded in April 1992, HDRI specializes in the design and management of clinical trials, postmarket surveillance programs, health economics, adverse event investigations, patient surveillance and other epidemiology-based services. HDRI professionals include physicians, epidemiologists, pharmacoeconomists and others with international reputations as health care scientists. Burr, Egan, Deleage and Co., with offices in San Francisco and Boston, invests nationwide in leading edge biomedical, biotechnology, health services, communications and electronic companies. The firm's recent health sciences investments include CIBUS Pharmaceutical Inc. Vanguard Medica Ltd., Depotech Corp., Ascent Pharmaceuticals Inc., Virx Inc., and Genset. -0- 8/23/93 /CONTACT: M. Reynolds Morgan of Health Devices Research Institute, 415-595-4866/
CO: Health Devices Research Institute; Burr, Egan, Deleage and Company ST: California IN: MTC SU: FNC
PK-LH -- SJ003 -- 5239 08/23/93 19:12 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Aug 23, 1993|
|Previous Article:||WASHINGTON STATE EMPLOYMENT SECURITY: INITIAL CLAIMS JUMP IN JULY|
|Next Article:||STEEL SERVICE CENTER SHIPMENTS EXPERIENCE MODEST SEASONAL DECLINE|